Ceritinib (LuciCer) 150mg*50's | Lucius Laos Generic | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

Делиться
Product description

Generic Information: LuciCer (Laos)

LuciCer is a Laotian generic of ceritinib manufactured by Lucius Pharmaceuticals, a Laos-based manufacturer widely used for affordable oncology and specialty medicines. Each capsule contains 150 mg of ceritinib, supplied in a 50-capsule pack. LuciCer delivers the same ALK-targeted therapy as the originator Zykadia at a markedly lower cost, aimed at patients who need reliable long-term treatment.

What Is LuciCer Used For?

LuciCer treats ALK-positive metastatic non-small cell lung cancer, particularly after disease progression on crizotinib. It is an oral targeted therapy for this molecularly defined lung-cancer subtype. The 50-capsule pack provides a practical mid-size supply that reduces the frequency of reordering while keeping the upfront cost manageable.

How Does Ceritinib (LuciCer) Work?

Ceritinib inhibits anaplastic lymphoma kinase, the driver protein behind ALK-rearranged NSCLC. By blocking ALK and related kinases, it suppresses the growth signals that cancer cells depend on and overcomes many of the ALK mutations that make tumours resistant to crizotinib. This makes LuciCer effective both as a subsequent line and, where approved, as upfront therapy.

Indications

The indication is ALK-positive metastatic NSCLC confirmed by a validated diagnostic test. LuciCer is used after crizotinib progression and as initial targeted therapy where locally approved. It is a prescription medicine that must be initiated and monitored by an oncologist.

Dosage

The recommended dose is 450 mg (three capsules) once daily with food, equivalent in efficacy to the 750 mg fasting regimen but better tolerated. A 50-capsule pack lasts about 16 days at this dose. Dose adjustments are made by the physician based on tolerability and liver-function monitoring.

Side Effects

Common side effects are diarrhoea, nausea, vomiting, abdominal pain, fatigue and loss of appetite. Important effects include elevated liver enzymes, hyperglycaemia, QT prolongation and, rarely, pneumonitis. Regular monitoring of liver function, blood glucose and heart rhythm is required throughout treatment.

Storage

Store LuciCer capsules at room temperature, away from moisture and light, in the original packaging and out of reach of children. Do not use past the expiry date.

Why Choose LuciCer Through GLT?

LuciCer offers an affordable ceritinib option for patients who need sustained ALK-targeted therapy. GLT supplies genuine Lucius Pharmaceuticals product through verified channels, with full documentation, and ships internationally from a Hong Kong-licensed facility — a dependable choice for long-term treatment in ALK-positive lung cancer.

How to Order

Contact GLT on WhatsApp at +86 15234153837 or by email at [email protected] to order LuciCer. We will confirm availability, pricing and shipping to your country before you place an order.

FAQ

Is LuciCer the same as Zykadia? Yes, LuciCer is a generic containing the same active ingredient ceritinib, with the same indication and dosing, at a lower cost.

Who manufactures LuciCer? LuciCer is manufactured by Lucius Pharmaceuticals in Laos.

How long does a 50-capsule pack last? At 450 mg once daily (three capsules), a pack lasts about 16 days.

Related Oncology Products

Rizonib (Кризотиниб) 250 мг капсулы | Дженерик Xalkori из Бангладеш (DIL) для ALK+ НМРЛ | GLT

Rizonib 250 от Drug International Ltd (DIL), Тонги Газипур — доступный дженерик кризотиниба из Бангладеш

Tixepa (Тирзепатид) 20мг/2мл и 30мг/2мл многодозовая ручка | Drug International | GLT

Tixepa — многодозовая ручка тирзепатида Drug International Limited (DIL), две официальные дозировки (Tixepa-5 = 20мг/2мл,...

Barinat (Барицитиниб) 4мг | Дженерик-ингибитор JAK1/JAK2 | Natco Pharma Limited | GLT

Дженерик барицитиниба (ингибитора JAK1/JAK2) от Natco Pharma Limited (Индия) — доступная альтернатива Olumiant при ревматоидном...

KangQuXin 康曲欣 (Аватромбопаг) 20 мг × 10 таблеток | Beijing Continent (Gyre) | GLT

KangQuXin — аватромбопаг от Beijing Continent Pharmaceutical (Gyre Therapeutics, Nasdaq: GYRE), Китай

Palutini (Барицитиниб) 4мг | Дженерик-ингибитор JAK1/JAK2 | Trans Continental Life Science & Pharmaceuticals (TLPH) | GLT

Дженерик барицитиниба (ингибитора JAK1/JAK2) от Trans Continental Life Science & Pharmaceuticals (TLPH) (Лаос) — доступная...

Baricent (Барицитиниб) 2мг | Дженерик-ингибитор JAK1/JAK2 | Incepta Pharmaceuticals Ltd. | GLT

Дженерик барицитиниба (ингибитора JAK1/JAK2) от Incepta Pharmaceuticals Ltd. (Бангладеш) — доступная альтернатива Olumiant при ревматоидном...

Элтромбопаг (Promacta) 25мг/50мг таблетки | Оригинальный TPO-R агонист из США | GLT

Оригинальный Promacta (элтромбопаг) от Novartis, 25 мг и 50 мг, 30 таблеток

XinKePing 欣可平 (Аватромбопаг) 20 мг × 10 таблеток | Nanjing Hencer, Китай | GLT

XinKePing — аватромбопаг Nanjing Hencer Pharmaceutical (группа Jemcare), полная вертикальная интеграция АФС и таблеток, материковый...